| dc.contributor.author | Hatemi, Gülen | |
| dc.contributor.author | YAZICI, Yılmaz | |
| dc.contributor.author | OZGULER, Yeşim | |
| dc.contributor.author | YAZICI, H | |
| dc.date.accessioned | 2021-03-02T20:53:24Z | |
| dc.date.available | 2021-03-02T20:53:24Z | |
| dc.identifier.citation | YAZICI H., OZGULER Y., Hatemi G., YAZICI Y., "Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.", Arthritis & rheumatology (Hoboken, N.J.), cilt.68, ss.1315-6, 2016 | |
| dc.identifier.issn | 2326-5191 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_0432909a-a233-41d6-8dd5-e89d428ab212 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/8762 | |
| dc.identifier.uri | https://doi.org/10.1002/art.39633 | |
| dc.language.iso | eng | |
| dc.title | Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al. | |
| dc.type | Makale | |
| dc.relation.journal | Arthritis & rheumatology (Hoboken, N.J.) | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 68 | |
| dc.identifier.startpage | 1315 | |
| dc.identifier.endpage | 6 | |
| dc.contributor.firstauthorID | 159770 | |